The prevalence of hypertension, diabetes, and dyslipidemia and baseline characteristics including age, BMI, FRS, SDP, DBP, UA, AST, ALT, and HbA1c in Q4 were higher than those in Q1–3 (p < 0.001). This evidence concerns the gene GPT and metabolic syndrome.